Found 147 presentations matching your search
Describing the Industry's/sponsor's/drug manufacturers' perspective of the Investigation...
Chemistry, Manufacturing, and Control (CMC) & Post Approval Regulatory Affairs; M. Pharmacy -Pha...
Basic information for beginners...
Presentation on Investigational New Drug (IND) enabling studies
This presentation gives a complete brief idea of how FDA regulates the marketing of Generic drugs. A...
Documentation In Pharmaceutical Industry(Master Formula Record,DMF,Distribution Record)
REGULATORY AND INDUSTRY VIEWS ON QbD
Project work ppt
A REVIEW PROJECT
Nicely described regarding about the overview of ICH guidelines as per PCI syllabus specially for Ph...
COMMON TECHNICAL DOCUMENT
Documentation in Pharmaceutical Industry - master formula record , DMF ( DRUG MASTER FILE )
Pharmacogenomics-Informed Pharmacovigilance: A New Paradigm for Personalized Drug Safety
The pharmaceutical Quantity by Design (QbD) is a systemic approach to development that begins with p...
Organization structure of USFDA
Facility Readiness: Goal Date Decisions Under GDUFA Guidance for Industry USFDA - 2022
#computer #pharmacy #drsiddhiupadhyay #sigmainstituteofpharmacy #preclinicaldevelopment
21 CFR Part 822 involves the guidelines about the post-marketing surveillance of the under-investiga...
Pharmaceutical regulatory affair is the interface between pharmaceutical industry and the regulatory...
Abbreviated New Drug, New Drug Application
Pharmaready ectd for small to medium size business
